P11, P12 & P13: Topical Drug Delivery Flashcards
what is the structure of the stratum corneum
bricks= dead keratin-filled cells
mortar= complex lipid mixture
has rivets holding corneocytes together are specialised protein structures called corneodesomes
what are corneodesomes
major structures to be degraded for desquamation of the skin
what are the pathways through the stratum corneum
transcellular
intercellular
via which pathway does H2O cross the stratum cornea
intercellular
what is the drug/delivery system supposed to do
modulate barrier function, treat disease states in the epidermis an dermis, alleviate local pain/inflammation in subcutaneous tissues, elicit systemic pharmacological effect
where is the therapeutic target and how accessible is it
surface, stratum corneum, viable epidermis/dermis, skin appendages, suncutaneous tissue, systemic circulation
what happens during percutaneous absorption
absorption of drugs from the skin surface into the body
drug penetrates into skin and is taken up by microcirculation
what does percutaneous absorption depend on
physiochemical properties of a drug, interactions of drug with vehicle or delivery system and with the skin, condition of the skin
how are topical formulations optimised
many are lipophilic with very low aqueous solubility
introduction of co-solvent into a formulation can increase Csat but this has the opposite effect on Ksc/v
how does pH of vehicle influence absorption
skin surface pH is acidic
unionised drugs best absorbed
extreme pH values damaging to skin, formulations mostly neutral
how does skin permeation affect absorption
some excipients, when incorporated in wehicle, can improve drug flux, but correlation between enhancement efficacy and skin irritation produced
what is the ideal vehicle in drug formulation
elicits no pharmacological effects, solubilises the drug, releases the drug with appropriate kinetics, is chemically and physically stable, is cosmetically appealing, is non-allergenic and non-irritating
what are the issues during drug formulation
interaction of vehicle with skin, interaction between drug and vehicle, no ‘rules’ for matching a formulation to a particular drug, enhancing delivery without irritating the skin
what physiochemical considerations need to be made during drug formulation
MW, lipophilicity, H-bonding, solubility in different solvents
how are formulations selected
type of emulsion, lipid content and occlusivity
what type of formulation is preferred for chronic skin disease
hydrocarbon-based formulations
how can drug solubility be enhanced
by formulation with hydrocarbon-miscible solvents like isopropyl myristate or propylene glycol
what is the water-free PEG-gel formulation
polar, 1-phase, semi-solid system, based on polyethylene glycols
what is the water-free lipogel formulation
polar, 1-phase, semi-solid system, principally based on triglyceride derivatives